首页 | 官方网站   微博 | 高级检索  
     

紫杉醇联合卡培他滨或氟尿嘧啶一线治疗晚期胃癌临床对照研究
引用本文:孙翠玲,田添,高莹莹,胡文军.紫杉醇联合卡培他滨或氟尿嘧啶一线治疗晚期胃癌临床对照研究[J].蚌埠医学院学报,2016,41(2):194-196.
作者姓名:孙翠玲  田添  高莹莹  胡文军
作者单位:安徽省阜阳市人民医院 肿瘤科, 安徽 236000
摘    要:目的:观察紫杉醇联合卡培他滨或氟尿嘧啶治疗晚期胃癌的疗效和不良反应。方法:76例晚期胃癌行化疗患者随机分为观察组和对照组,各38 例。观察组采用紫杉醇联合卡培他滨方案,紫杉醇150 mg/m2(总量,第 1、8天),加入0.9%氯化钠注射液,3 h缓慢静脉滴注;卡培他滨750 mg/m2,每天2 次,第1~14 天口服。对照组采用紫杉醇联合氟尿嘧啶方案,紫杉醇用法同观察组;氟尿嘧啶500 mg/m2,每天1 次,连用5 d,使用前2 h 静脉滴注亚叶酸钙130 mg/m2。结果:观察组总有效率52.63%,对照组50.00%,2组差异无统计学意义(P>0.05);观察组中位无进展时间6.7个月,中位生存时间11.8个月,对照组中位无进展时间6.2个月,中位生存时间11.3个月,2组1年生存率差异无统计学意义(P>0.05);观察组化疗主要不良反应中,手足综合征发生率明显高于对照组(P<0.01)。结论:紫杉醇联合卡培他滨或氟尿嘧啶治疗晚期胃癌疗效相近,患者耐受性好。

关 键 词:胃肿瘤    紫杉醇    卡培他滨    氟尿嘧啶
收稿时间:2014-06-27

Clinical comparsion between paclitaxel combined with capecitabine and fluorouracil in the first-line treatment of advanced gastric cancer
SUN Cui-ling,TIAN Tian,GAO Ying-ying,HU Wen-jun.Clinical comparsion between paclitaxel combined with capecitabine and fluorouracil in the first-line treatment of advanced gastric cancer[J].Journal of Bengbu Medical College,2016,41(2):194-196.
Authors:SUN Cui-ling  TIAN Tian  GAO Ying-ying  HU Wen-jun
Affiliation:Department of Oncology, The People's Hospital of Fuyang, Fuyang Anhui 36000, China
Abstract:Objective:To observe the effects and adverse reactions of paclitaxel combined with capecitabine or fluorouracil in the treatment of advanced gastric cancer. Methods:Seven-six patients with advanced gastric cancer were randomly divided into the observation group and control group ( 38 cases each group ) . The observation group were treated with paclitaxel combined with capecitabine,the mixture of 150 mg/m2 of paclitaxel(at day 1 and 8) and 0. 9% sodium chloride injection was intravenously injected for 3 h,and the 750 mg/m2 of capecitabine was used by oral 2 times daily from day 1 to 14. The control group were treated with paclitaxel combined with fluorouracil,the usage of paclitaxel was the same as the observation group,the 500 mg/m2 of 5-fluorouracil was used once a day for 5 d after 2 h of the 130 mg/m2 of leucovorin calcium intravenous dripping. Results:The effective rates of the observation group and control group were 52. 63%,and 50. 00%,respectively,the difference of which was not statistically significant (P>0. 05). The median progression-free time and median survival time in observation group and control group were 6. 7 months &11. 8 months and 6. 2 months&11. 3 months,respectively. The difference of 1-year survival rate between two groups was not statistically significant(P>0. 05). The incidence of hand-foot syndrome in observation group was significantly higher than that in control group (P<0. 01). Conclusions:The effects of paclitaxel combined with capecitabine or fluorouracil in the treatment of advanced gastric cancer are similar,the tolerance of patients is good.
Keywords:gastric neoplasm  paclitaxel  capecitabine  fluorouracil
本文献已被 万方数据 等数据库收录!
点击此处可从《蚌埠医学院学报》浏览原始摘要信息
点击此处可从《蚌埠医学院学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号